Jana Care

Jana Care

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $17.8M

Overview

Jana Care is a private, pre-revenue diagnostics company pioneering a low-cost, smartphone-integrated platform for decentralized chronic disease monitoring. Its three-part approach involves paper-based test strips, a smartphone accessory reader, and a connected data ecosystem to link patients with clinicians. Initially focused on Congestive Heart Failure (CHF) and Chronic Kidney Disease (CKD), the company has deployed its technology in over 1,500 clinics, serving more than 200,000 patients primarily in India, though its device is not yet FDA-cleared or commercially available in the US. The business model targets prescription-based testing to identify patients needing clinical follow-up, aiming to improve outcomes and reduce costly hospitalizations.

Cardiovascular DiseaseRenal Disease

Technology Platform

Integrated diagnostic system combining proprietary paper-based microfluidic test strips with a smartphone-based reader device (Aina) and a connected software platform for remote patient monitoring and telehealth integration.

Funding History

2
Total raised:$17.8M
Series A$15M
Seed$2.8M

Opportunities

The global shift towards value-based care and remote patient monitoring creates a massive opportunity for low-cost, connected diagnostics to reduce hospital readmissions for CHF and CKD.
Success in India provides a blueprint for scaling in other emerging markets with high chronic disease burdens and cost constraints.

Risk Factors

The primary risk is regulatory, as the Aina device lacks FDA clearance for the U.S.
market.
Commercial success also hinges on proving cost-effectiveness to secure reimbursement from payers and competing in a crowded digital health landscape with established players.

Competitive Landscape

Jana Care competes in the remote patient monitoring and point-of-care diagnostics space. Key competitors include established diagnostics companies (e.g., Abbott, Roche) with handheld readers, digital health startups offering connected devices, and traditional telehealth platforms. Jana Care's differentiation is its ultra-low-cost paper-and-smartphone model, targeting affordability and scalability.